The incidence of tuberculosis in patients treated with certolizumab pegol across indications: impact of baseline skin test results, more stringent screening criteria and geographic region

OBJECTIVES: We report the incidence of tuberculosis (TB) across certolizumab pegol (CZP) clinical trials in rheumatoid arthritis (RA), psoriasis, psoriatic arthritis (PsA) and axial spondyloarthritis (axSpA), before and after the introduction of stricter TB screening. METHODS: TB incidence rates (IR...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:RMD Open
Asıl Yazarlar: Mariette, X, Vencovsky, J, Lortholary, O, Gomez-Reino, J, de Longueville, M, Ralston, P, Weinblatt, M, van Vollenhoven, R
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BMJ Publishing Group 2015
Konular:
Rheumatoid Arthritis
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4613160/
https://ncbi.nlm.nih.gov/pubmed/26509064
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/rmdopen-2014-000044
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller